Final Call to Join GPAS 2025: A Crucial Dialogue on Global Access to Medicines
The World Federation of Hemophilia (WFH) recently shared an inviting post on X:
”This is your last chance to register for tomorrow’s GPAS 2025! Don’t miss leading voices from the WHO, Deusdedit Mubangizi, Director, Access to Medicines and Health Products Division, and Lorenzo Moja, Team Lead, WHO EML Secretariat.
”
Register here.
As the world continues to confront persistent challenges in equitable healthcare access, the upcoming GPAS 2025 summit offers a timely and vital platform for international collaboration and insight.
Taking place tomorrow, the event will spotlight leading voices from the World Health Organization (WHO), including Deusdedit Mubangizi, Director of the Access to Medicines and Health Products Division, and Dr. Lorenzo Moja, Team Lead of the WHO Essential Medicines List (EML) Secretariat.
Their participation underscores the urgency of addressing barriers to essential medicines and advancing health equity through evidence-based policy and global coordination.
This is the final opportunity to register for what promises to be a pivotal moment in the global public health calendar.
Don’t miss your chance to engage in shaping the future of access to medicines and health products worldwide.
Stay updated on the upcoming webinars and summits with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis